|
已选(0)清除
条数/页： 排序方式：
|
| INCREASED BONE MARROW (BM) PLASMA LEVELS OF SOLUBLE CD30 CORRELATE WITH BM PLASMA LEVELS OF INTERFERON (IFN)-GAMMA, CD4/CD8 T-CELL RATIO AND DISEASE SEVERITY IN APLASTIC ANEMIA 会议论文
HAEMATOLOGICA, 2014-06-01
作者: Zhang, J.; Zheng, Y.
  收藏 | 浏览/下载：2/0 | 提交时间：2020/01/13 |
| Robustness analysis of the IFN-gamma induced JAK-STAT signaling pathway 会议论文
JOURNAL OF COMPUTER SCIENCE AND TECHNOLOGY, 2nd Tsinghua International Bioinformatics Workshop, Tsinghua, PEOPLES R CHINA, Web of Science
Zi, ZK; Sun, ZR
收藏 | 浏览/下载：4/0 |
| 脊椎动物干扰素调节因子(Irf)家族基因起源进化初探 会议论文
-, -, -
黄贝; 聂品; 齐志涛; 徐镇
收藏 | 浏览/下载：369/0 | 提交时间：2011/03/21 |
| 鲫鱼干扰素诱导表达基因Gig1的初步功能研究 会议论文
蒋珺; 张义兵; 桂建芳
收藏 | 浏览/下载：189/67 | 提交时间：2011/03/21 |
| Imatinib is cost-effective comparing to interferon-(IFN) for patients with newly diagnosed chronic-phase (CP) chronic myeloid leukemia (CML) from the chinese public healthcare system perspective. 会议论文
作者: Wang, Chun; Chen, Zi; Feng, Weiwei
收藏 | 浏览/下载：1/0 | 提交时间：2019/12/19 |
| Imatinib versus interferon-alpha (IFN) for patients with newly diagnosed chronic-phase (CP) chronic myeloid leukemia (CML) from the chinese public healthcare system perspective: 12 months cost and cost per responder analyses. 会议论文
作者: Wang, Chun; Chen, Zi; Feng, Weiwei
收藏 | 浏览/下载：6/0 | 提交时间：2019/12/19 |
| Comparison of 12-month treatment costs for patients with advanced phase chronic myeloid leukemia (CML) in China: Imatinib (IM) vs. chemotherapy (Chemo) plus interferon-(IFN) in accelerated phase (AP) CML and IM vs. chemo in blast crisis (BC) CML. 会议论文
作者: Chen, Zi; Wang, Chun; Feng, Weiwei
收藏 | 浏览/下载：2/0 | 提交时间：2019/12/27 |
| Comparison of 12-month treatment costs for patients with advanced phase chronic myeloid leukemia (CML) in China: Imatinib (IM) vs. chemotherapy (Chemo) plus interferon-(IFN) in accelerated phase (AP) CML and IM vs. chemo in blast crisis (BC) CML. 会议论文
作者: Chen, Zi; Wang, Chun; Feng, Weiwei
收藏 | 浏览/下载：1/0 | 提交时间：2019/12/27 |
| 鱼类干扰素系统基因的克隆鉴定及其特征分析 会议论文
张义兵; 桂建芳
收藏 | 浏览/下载：8/0 | 提交时间：2011/03/21 |
